Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medivation Inc.: Today's Featured Health Care Leader
The Street
Saturday, July 21, 2012 - 11:33am
tags:
Medivation
UniQure’s Glybera Wins EU Backing As First Gene Therapy
Bloomberg
Saturday, July 21, 2012 - 11:30am
tags:
uniQure, Glybera
Onyx Wins U.S. FDA Approval For Blood Cancer Treatment
Bloomberg
Saturday, July 21, 2012 - 11:27am
tags:
ONYX Pharmaceuticals, Kyprolis, Multiple Myeloma
Vivus falls on concerns of patent protection for diet pill
Reuters
Friday, July 20, 2012 - 10:42am
tags:
Vivus, Qsymia, patents
Court upholds Pfizer's Lyrica patent protection
Reuters
Friday, July 20, 2012 - 10:40am
tags:
Pfizer, generics, patents, Lyrica
Cubist Increases Revenue 30% to $231 Million in the Second Quarter
Yahoo
Friday, July 20, 2012 - 10:34am
tags:
earnings, Cubist
Amarin Shares Trade Higher on Hope for Fish-Oil Drug
Minyanville
Friday, July 20, 2012 - 10:33am
tags:
AMR-101, Amarin, fish oil
Biogen Idec Second Quarter Earnings Preview
Investopedia.com
Friday, July 20, 2012 - 10:31am
tags:
BiogenIdec, earnings
Merck: Experts In Patent Cliff Management
Motley Fool
Friday, July 20, 2012 - 10:31am
tags:
patents, Merck, patent cliff
Report: J&J will pay as much as $2.2B to resolve investigation of Risperdal marketing
Yahoo/AP
Friday, July 20, 2012 - 10:28am
tags:
JNJ, Risperdal, settlements
Merck: New Sleeping Pill Thwarts Brain’s Up-All-Night Neurons
Bloomberg
Friday, July 20, 2012 - 9:33am
tags:
Merck, insomnia, orexin receptors, GSK, Takeda
The Market Has Already Discounted Merck's New Drug
Seeking Alpha
Friday, July 20, 2012 - 9:30am
tags:
Merck, Abbott Labs, Amgen, GSK, Pfizer, Eli Lilly, osteoporosis, Odanacatib
Roche’s Secret Heart Drug Moves Toward Late-Stage Trial
Bloomberg
Friday, July 20, 2012 - 9:29am
tags:
Roche, Sanofi, PCSK9 inhibitor, Regeneron, Amgen
Pfizer's Crizotinib receives positive opinion from CHMP
Yahoo/Fly on the Wall
Friday, July 20, 2012 - 9:26am
tags:
Pfizer, crizotinib, CHMP, small cell lung cancer
Horizon Pharma Moving Ahead of FDA Decision
Yahoo
Friday, July 20, 2012 - 9:24am
tags:
Rayos, rheumatoid arthritis, Horizon Pharma
Plavix tops U.S. sales ranks, but not for long
Fierce Pharma
Thursday, July 19, 2012 - 3:31pm
tags:
Plavix, Bristol-Myers Squibb
India: pharmaceutical companies to stop giving gifts to physicians
HealthIndia
Thursday, July 19, 2012 - 3:18pm
tags:
India, physician gifts
J&J Escapes Class Action Lawsuit Over Recalls
Pharmalot
Thursday, July 19, 2012 - 3:15pm
tags:
JNJ, recalls, Class Action Lawsuit
Infinity restructures drug deal, raises $27.5M as it scrambles to refocus
Fierce Biotech
Thursday, July 19, 2012 - 9:51am
tags:
Infinity Pharmaceuticals, Purdue, restructuring
Novartis Sues Sun Over Proposed Generic Zometa, Reclast
Bloomberg
Thursday, July 19, 2012 - 9:21am
tags:
Sun Pharma, Novartis, generics, Reclast, Zometa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.